AI assistant
Sending…
Skye Bioscience, Inc. — Director's Dealing 2014
Nov 11, 2014
34097_dirs_2014-11-10_8d81281f-3e28-410b-84f6-7e1f9fb1776c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Nemus Bioscience, Inc. (LGLRD)
CIK: 0001516551
Period of Report: 2014-10-31
Reporting Person: Murphy Brian Stuart (Chief Medical Officer)
More from Skye Bioscience, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Delisting Announcement
2026
May 15
Annual Report
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 3
Delisting Announcement
2026
Mar 19
Board/Management Information
2026
Feb 20
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10